Log in to search using one of your social media accounts:


Family From Ireland Hopes Boston Doctors Can Save Boy’s Life

BOSTON (CBS) — Cian McDonnell-Lynch is just four years old. He’s been given until Christmas to live. His family, saying they refuse to give up, has traveled to Boston Children’s Hospital in the hopes that one of the world’s premiere hospitals can help keep him alive. Cian has been fighting an often deadly bone marrow disorder called Dyskeratosis Congenita since birth. “It’s a very rare disease,” his mother, Lisa McDonnell, told WBZ-TV Tuesday. “It affects one in a million. And Cian is actually at the more severe end of the syndrome.” Cian McDonnell-Lynch and his family in Boston (WBZ-TV) The disease left Cian permanently blind at the age of one. He did get a successful bone marrow transplant two years ago, but the disease is now affecting his lungs with another rare and deadly disorder, microscopic pulmonary AVMS. “They’re actually microscopic blood vessels; they’re malformations,” his mother explained. “And the oxygenated blood is not getting around to his whole body.” “We were told today that it’s actually progressing very quick, so we’re just really really hoping that he’ll be accepted onto the transplant list here in Boston.” Cian has been given only a few months to live. A double-lung transplant would likely save his life, but he was rejected for one at a hospital in London. “He was the first child that they’ve seen with this condi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Local News Syndicated Local Cian McDonnell-Lynch Hope For Cian liam martin Source Type: news

Related Links:

(MedPage Today) -- Noteworthy presentations at American Academy of Neurology meeting
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
Their first collaboration, Spinraza, a treatment for a deadly rare disease called spinal muscular atrophy, generated $884 million sales last year, its first on the market.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:BIIB NASDAQ:IONS Source Type: news
AbstractBackgroundAngioimmunoblastic T cell lymphoma is a rare malignancy, accounting for only 2% of all non-Hodgkin lymphomas, first described in the 1970s and subsequently accepted as a distinct entity in the current World Health Organization classification. Due to the paucity of this disease, there is still no identifiable etiology, no consistent risk factors, and the pathogenesis remains unclear.Case presentationAn 83-year-old Caucasian man presented to an emergency department with palpitations and was found to have atrial fibrillation. During his hospitalization, he was found to have asymptomatic hypercalcemia with co...
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
Cryopyrin-associated periodic syndrome (CAPS) is a rare disease. Knowledge on the quality of life (QoL) and the disease ’s societal impact is limited. Canakinumab is used in increasing frequency for the treatme...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Tags: Research Source Type: research
Pulmonary hemosiderosis is a rare and complex disease in children. A previous study from the French RespiRare ® network led to two important findings: 20% of the children presented with both pulmonary hemosider...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Tags: Research Source Type: research
Pemphigus vulgaris (PV) is a complex, multifactorial, and polygenic disease, whose exact pathogenesis is difficult to pinpoint. Research aimed at further elucidating associated epidemiologic risk factors is hampered by its rare disease status. Further, a lack of centralization and standardization of available data makes the practical application of this information challenging. We comprehensively reviewed 90 PV articles from 26 different countries for parameters including age, sex, ethnicity, incidence, prevalence, and HLA allele association.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Clinical Research: Epidemiology of Skin Diseases Source Type: research
Scleromyxedema is a disease characterized by papular mucinous deposits, dermal fibroblast proliferation, and is associated with monoclonal paraproteinemia. Systemic manifestations can lead to significant morbidity and mortality. Being an extremely rare disease, its prevalence and clinical course are poorly reported. We sought to describe the characteristics of patients with scleromyxedema regarding clinical characteristics, psychological impact, therapeutic interventions, and course through anonymous online questionnaire.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Clinical Research: Epidemiology of Skin Diseases Source Type: research
Japan has taken measures for specially defined rare diseases, called Nan-Byo (difficult-illness) in Japanese since 1972. While this governmental support has benefited Nan-Byo patients, those suffering from unidentified conditions do not fall into the scheme and cannot receive subsidies nor chances for consultation. To identify such rare and often undiagnoseddiseases, we must integrate systematic diagnosis by medical experts through global data matching, thereby solving the Nof1 problem. Thus, AMED launched the Initiative on Rare and Undiagnosed Diseases (IRUD) to construct a holistic medical network utilizing the existing ...
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Genetic Disease, Gene Regulation, and Gene Therapy Source Type: research
Abstract: Idiopathic pulmonary fibrosis (IPF) is a rare disease characterized by decline in lung function, dyspnea, and cough. The clinical course of IPF is variable and unpredictable. Early referral to specialists is key to ensure timely and accurate diagnosis. Two antifibrotic drugs (nintedanib and pirfenidone) have been approved for the treatment of IPF.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: LUNG DISEASE Source Type: research
Source: ScienceNOW - Category: Science Authors: Tags: Cell Biology, Medicine, Diseases twis Source Type: news
More News: Bone Marrow Transplant | Cardiology | Children | Fundraising | Health | Heart | Heart Transplant | Hospitals | Insurance | Ireland Health | Learning | Lung Transplant | Rare Diseases | Sports Medicine | Transplant Surgery | Transplants | Universities & Medical Training